Overview

Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis

Status:
Completed

Trial end date:
2009-04-01

Target enrollment:

Participant gender:

Summary

At the end of the study, safety and efficacy outcome measures will be compared to determine a) if dosing with Generic Imiquimod cream, 5% is therapeutically equivalent to the currently marketed Aldara (imiquimod) cream, 5% and b) if both imiquimod 5% creams are superior in comparison to the Vehicle cream.

Phase:

Phase 3

Details

Lead Sponsor:

Actavis Inc.
Actavis Mid-Atlantic LLC

Treatments:

Imiquimod